Hangzhou Biotest Biotech Co Ltd (688767) — Tangible Net Worth Ratio
Hangzhou Biotest Biotech Co Ltd (688767) has a Tangible Net Worth Ratio of 88.7% as of March 2026. This metric is calculated by deducting intangible assets (CN¥267.89 Million) from net assets (CN¥2.36 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of Hangzhou Biotest Biotech Co Ltd for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hangzhou Biotest Biotech Co Ltd Tangible Net Worth Ratio (2017–2025)
This chart shows how Hangzhou Biotest Biotech Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 88.7%, reflecting net assets of CN¥2.36 Billion with intangible assets of CN¥267.89 Million CNY. Also explore 688767 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Hangzhou Biotest Biotech Co Ltd (2017–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Hangzhou Biotest Biotech Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 688767 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.6% | CN¥2.37 Billion | CN¥269.31 Million | CN¥2.54 Billion | ▲ +0.0 pp |
| 2024 | 88.6% | CN¥2.41 Billion | CN¥275.16 Million | CN¥2.60 Billion | ▼ -2.8 pp |
| 2023 | 91.4% | CN¥2.42 Billion | CN¥208.71 Million | CN¥2.58 Billion | ▼ -0.3 pp |
| 2022 | 91.7% | CN¥2.56 Billion | CN¥213.71 Million | CN¥2.75 Billion | ▼ -7.4 pp |
| 2021 | 99.0% | CN¥2.11 Billion | CN¥20.35 Million | CN¥2.43 Billion | ▲ +3.7 pp |
| 2020 | 95.3% | CN¥443.02 Million | CN¥20.75 Million | CN¥633.92 Million | ▲ +12.2 pp |
| 2019 | 83.1% | CN¥125.95 Million | CN¥21.33 Million | CN¥210.44 Million | ▲ +5.1 pp |
| 2018 | 78.0% | CN¥98.15 Million | CN¥21.58 Million | CN¥154.63 Million | ▲ +5.6 pp |
| 2017 | 72.4% | CN¥79.63 Million | CN¥21.99 Million | CN¥127.52 Million | — |